Turning Point Brands (TPB) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The date of the 2025 annual meeting was changed to May 6, 2025, to comply with the requirement to hold the meeting within 60 days of the record date.
The annual meeting will be held exclusively online via live webcast, with access instructions provided to shareholders.
All other information and instructions in the original proxy statement and proxy card remain unchanged.
Voting matters and shareholder proposals
Deadlines for submitting shareholder proposals for the 2026 annual meeting have been updated to January 12, 2026 (earliest) and February 11, 2026 (latest).
Proposals must be sent in writing to the Corporate Secretary at the company's headquarters.
Proxies for the 2025 meeting may exercise discretionary authority on properly brought proposals.
Board of directors and corporate governance
The notice and changes were issued by the General Counsel and Corporate Secretary on behalf of the Board of Directors.
Latest events from Turning Point Brands
- Modern Oral net sales jumped 266%, driving 29% overall revenue growth and strong 2026 outlook.TPB
Q4 20252 Mar 2026 - Q2 sales and EBITDA rose, guidance increased, and net income jumped 31% on strong segment growth.TPB
Q2 20242 Feb 2026 - Q3 2024 saw double-digit profit growth, raised guidance, and expanded share buybacks.TPB
Q3 202415 Jan 2026 - FY2024 net sales up 11% and EBITDA up 12%, with strong modern oral and core brand growth.TPB
Q4 202416 Dec 2025 - Board recommends voting for all proposals, emphasizing diversity and governance improvements.TPB
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor change, officer liability limits, and executive pay approval.TPB
Proxy Filing1 Dec 2025 - Modern Oral sales soared 651%, driving 25% revenue growth and higher full-year guidance.TPB
Q2 202523 Nov 2025 - Q1 2025 net sales up 28.1%, net income up 19.8%, and Modern Oral sales guidance raised.TPB
Q1 202519 Nov 2025 - Modern Oral sales soared 628% year-over-year, driving record Q3 growth and raised guidance.TPB
Q3 202513 Nov 2025